Posts by rw-admin
Integra LifeSciences to Acquire ACell for $300M
Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc. (“ACell”) for an upfront cash payment of $300 million at closing, subject to customary purchase price adjustments, and cash payments of up to an additional $100 million upon the achievement of certain…
Read MoreSoniVie Receives FDA Breakthrough Device Designation for Therapeutic Intravascular Ultrasound
SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, today announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the TIVUS System for renal artery denervation for the treatment of resistant hypertension, which is defined…
Read MoreVolta Medical Receives FDA Clearance for AI Cardiac Electrophysiology Software
Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time…
Read MoreOlympus Buys Veran Technologies for $340M
Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA) and will be the latest in a…
Read MoreNeuroOne Medical Announces First Human Commercial Use of its Evo Cortical Electrode at Mayo Clinic
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the first human commercial use of its Evo Cortical Electrode at Mayo Clinic in Rochester, Minnesota. The procedure was performed by Jamie Van Gompel, M.D., from November 23rd through November 27th on a patient that had…
Read MoreZimmer Biomet Picks up Chest Surgery Toolmaker A&E Medical for $250M
Vance Street Capital LLC (“Vance Street”) is pleased to announce it has completed the sale of A&E Medical Corporation (“A&E Medical”) to Zimmer Biomet (NYSE: ZBH) (“Zimmer”), a global leader in musculoskeletal healthcare, for $250 million. The transaction marks the second exit out of Vance Street’s Sophomore Fund. Founded in 1968 and headquartered in Farmingdale,…
Read MoreTHINK Surgical Receives FDA Clearance of Second-Generation Active Robot
THINK Surgical, an innovator in the field of orthopedic active robot surgery, announced today that the Food and Drug Administration (FDA) has cleared the second-generation of the TSolution One Total Knee Application. The system features an active robot for total knee replacement, providing fully automated bone preparation, and gives surgeons a choice of implant options.…
Read MoreMMI’s Symani Robotic Microsurgery System Cleared in Europe
MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the CE Mark, launch and first human use of its Symani® Surgical System in Europe for open microsurgical procedures. The first four robotic surgeries were successfully performed in Florence, Italy, including three complex, post-traumatic lower limb reconstructions as well…
Read MoreAllotrope Medical Announces FDA Clearance of StimSite
Allotrope Medical™ Inc., a company committed to advancing surgical safety and precision, today announced its FDA clearance of their device, StimSite. StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation. Ureter identification is a critical step in safely advancing…
Read MoreAdagio Medical Raises $42.5 Million In Series E Financing
Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™), today announced that it has closed a $42.5 million Series E equity financing. Proceeds from the financing will be used to support the ongoing iCLAS™ Investigational Device Exemption (IDE) trial, accelerate the European VT CE-Mark…
Read More